ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

NCI RFA: Basic Biobehavioral Research

August 6, 1999

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

NCI Cancer Prevention Fellowship Program

April 28, 2000

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995